{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:08:19Z","timestamp":1726506499272},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.pupt.2013.03.014","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T12:01:31Z","timestamp":1364299291000},"page":"609-616","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis"],"prefix":"10.1016","volume":"26","author":[{"given":"F.","family":"Blasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schaberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Rosignoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dionisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.03.014_bib1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"issue":"Suppl. 6","key":"10.1016\/j.pupt.2013.03.014_bib2","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.pupt.2013.03.014_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.03.014_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.03.014_bib5","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.pupt.2013.03.014_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1164\/rccm.201206-0996OC","article-title":"Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease","volume":"186","author":"Llor","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.03.014_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1378\/chest.113.6.1542","article-title":"Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function","volume":"113","author":"Eller","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.03.014_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0924-8579(01)00435-6","article-title":"Randomised, double bind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis","volume":"18","author":"Masterton","year":"2001","journal-title":"Intern J Antimicrob Agents"},{"issue":"19","key":"10.1016\/j.pupt.2013.03.014_bib9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2165\/00003495-200464190-00005","article-title":"Prulifloxacin","volume":"64","author":"Keam","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2013.03.014_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513953","article-title":"Community-acquired pneumonia in adults: guidelines for management","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Inf Dis"},{"issue":"2","key":"10.1016\/j.pupt.2013.03.014_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/pupt.2001.0289","article-title":"Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of placebo-controlled randomized study","volume":"14","author":"Allegra","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2013.03.014_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.rmed.2004.10.020","article-title":"Sputum color as a marker of acute bacterial exacerbation of acute exacerbations of chronic obstructive pulmonary disease","volume":"99","author":"Allegra","year":"2005","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.pupt.2013.03.014_bib13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.rmed.2005.03.019","article-title":"Proposal for a multidimensional staging system for chronic obstructive pulmonary disease","volume":"99","author":"Celli","year":"2005","journal-title":"Respir Med"},{"issue":"24","key":"10.1016\/j.pupt.2013.03.014_bib14","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2165\/00003495-200363240-00008","article-title":"Levofloxacin: a review of its use in the treatment of bacterial infections in the United States","volume":"63","author":"Croom","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pupt.2013.03.014_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1179\/joc.2005.17.2.138","article-title":"Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin","volume":"17","author":"Montanari","year":"2005","journal-title":"J\u00a0Chemother"},{"issue":"20","key":"10.1016\/j.pupt.2013.03.014_bib16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.2010.672","article-title":"Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease","volume":"303","author":"Rothberg","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"year":"2011","series-title":"EMA-pharmacovigilance working party monthly report","key":"10.1016\/j.pupt.2013.03.014_bib17"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2013.03.014_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pupt.2005.09.007","article-title":"Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis","volume":"19","author":"Cazzola","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.pupt.2013.03.014_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1753465808094914","article-title":"Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers","volume":"2","author":"Pasqua","year":"2008","journal-title":"Ther Adv Respir Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2013.03.014_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pupt.2005.09.009","article-title":"Pharmacologic characteristics of prulifloxacin","volume":"19","author":"Matera","year":"2006","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T18:56:51Z","timestamp":1539802611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1094553913000886"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.03.014","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2013.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}